Pharmaceuticals

We collaborate with the world for the health of everyone in it.
Learn more
Pharma

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we envision a world without disease. To achieve this, we strive to couple our strong internal capabilities with the most compelling external science to transform how diseases are thought of being treated, cured, prevented and intercepted in the future.

Focus Areas

Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. We seek innovation across all of these areas where there is significant unmet patient need.

CLICK a circle below to see the diseases we are targeting.

  •  
  •  
  •  
  •  
  •  
  •  
 
  •  
    Cardivascular and Thrombosis,
    Retinal Diseases,
    Metabolism/NASH,
    Renal Disease
    Cardiovascular and Metabolism
    Cardiovascular and Metabolism
  •  
    Gastroenterology,
    Rheumatology,
    Immuno Dermatology,
    IL-23 Pathway
    Immunology
    Immunology
  •  
    Viral Hepatitis & Adjacent Liver Diseases,
    Prevention & Treatment of Viral & Bacterial Respiratory Infections,
    Adjuvants, Novel Viral Vectors & Vaccine Technologies
    Infectious
    Diseases and Vaccines
    Infectious Diseases and Vaccines
  •  
    Mood Disorders,
    Neurodegenerative Disorders including Multiple Sclerosis,
    Glutamatergic Pathway Diseases,
    Schizophrenia
    Neuroscience
    Neuroscience
  •  
    Prostate Cancer,
    Hematologic Malignancies,
    Solid Tumor Targeted Therapy,
    Immuno-Oncology
    Oncology
    Oncology
  •  
    Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis
    Pulmonary Hypertension
    Pulmonary Hypertension
Collaboration Partners

Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities. 

Text left

JLABSlogo-jlabs-web.png
If you are seeking incubation space for your early-stage company, or seeking to expand your start-up through an exchange of ideas and collaboration, make the connection with our incubation teams.

Text right

Innovation Centerslogo-ic-web.png
If you are an entrepreneur or with an early-stage consumer or medical device company, or a biopharmaceutical company seeking a collaboration to advance a program which is pre-proof of concept in humans, make the connection with our Johnson & Johnson Innovation team.

Text left

JJDClogo-jjdc-web.png
If you are with a consumer, medical device or biopharmaceutical company and seek a strategic venture partner, make the connection with our Johnson & Johnson Innovation – JJDC, Inc. team.

Text right

JBDlogo-jbd-web.png
If you are an established pharmaceutical company, or mid-sized to large biotechnology company, and seek a collaboration or merger & acquisition discussion, make the connection with our Johnson & Johnson Innovation, Janssen Business Development team.

Contact us

Make the Connection

We look forward to our first discussion. If you would like to discuss a collaboration,
please connect with us and we will schedule a call soon.

contact